$QIND
Quality Industrial Corp. Stock $qind

$qind Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-K Financial Statement

#000121390024030968 Filed on April 08, 2024

Income Statement

Concept	2024 Q2	2023 Q4	2023 Q2
Revenue	$3.317M	$0.00	$21.60M
YoY Change	-84.64%	-100.0%
Cost Of Revenue	$2.069M	$0.00	$13.66M
YoY Change	-84.86%	-100.0%
Gross Profit	$1.248M	$0.00	$7.940M
YoY Change	-84.27%	-100.0%
Gross Profit Margin	37.64%		36.75%
Selling, General & Admin	$825.4K	$2.704M	$2.609M
YoY Change	-68.36%	-34.42%	13118.46%
% of Gross Profit	66.11%		32.85%
Research & Development			$14.22K
YoY Change			-75.7%
% of Gross Profit			0.18%
Depreciation & Amortization	$37.56K	$0.00	$653.0K
YoY Change	-94.25%	-100.0%	15.58%
% of Gross Profit	3.01%		8.22%
Operating Expenses	$825.4K	$2.704M	$3.330M
YoY Change	-75.21%	-34.42%	3572.7%
Operating Profit	$423.1K	-$2.704M	$4.610M
YoY Change	-90.82%	-149.03%	-5185.18%
Interest Expense	-$78.74K	-$137.5K	-$1.010M
YoY Change	-92.21%	-95.45%	-104059.16%
% of Operating Profit	-18.61%		-21.92%
Other Income/Expense, Net	-$30.74K	-$1.320M	-$1.757M
YoY Change	-98.25%	-58.92%	422.88%
Pretax Income	$392.3K	-$4.162M	$2.853M
YoY Change	-86.25%
Income Tax	$43.89K
% Of Pretax Income	11.19%
Net Earnings	$130.3K	-$4.162M	$2.853M
YoY Change	-95.43%	-262.21%	1062.24%
Net Earnings / Revenue	3.93%		13.21%
Basic Earnings Per Share	$0.00		-$0.01
Diluted Earnings Per Share	$0.00	-$0.04	$0.03
COMMON SHARES
Basic Shares Outstanding	128.0M shares	126.9M shares	114.4M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2024 Q2	2023 Q4	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$101.2K	$2.490K	$3.211M
YoY Change	-96.85%
Cash & Equivalents	$101.2K	$2.492K	$1.708M
Short-Term Investments			$1.503M
Other Short-Term Assets	$2.000M	$2.354M	$4.944M
YoY Change	-59.54%	-97.87%
Inventory	$1.104M		$1.536M
Prepaid Expenses
Receivables	$2.112M		$60.41M
Other Receivables	$2.700M		$0.00
Total Short-Term Assets	$5.870M	$2.357M	$116.7M
YoY Change	-94.97%	-97.89%	498285.0%
LONG-TERM ASSETS
Property, Plant & Equipment	$85.13K		$32.13M
YoY Change	-99.74%
Goodwill	$8.479M		$56.39M
YoY Change	-84.96%
Intangibles
YoY Change
Long-Term Investments	$0.00	$6.500M
YoY Change
Other Assets			$88.52M
YoY Change
Total Long-Term Assets	$10.60M	$6.500M	$88.52M
YoY Change	-88.02%	-92.7%
TOTAL ASSETS
Total Short-Term Assets	$5.870M	$2.357M	$116.7M
Total Long-Term Assets	$10.60M	$6.500M	$88.52M
Total Assets	$16.47M	$8.857M	$205.2M
YoY Change	-91.97%	-95.59%	876348.88%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$894.3K	$166.6K	$41.01M
YoY Change	-97.82%	-99.62%
Accrued Expenses	$69.60K	$154.0K	$2.290M
YoY Change	-96.96%	-87.23%
Deferred Revenue
YoY Change
Short-Term Debt	$2.332M	$0.00	$18.91M
YoY Change	-87.67%
Long-Term Debt Due	$4.932M
YoY Change
Total Short-Term Liabilities	$8.638M	$5.782M	$143.6M
YoY Change	-93.99%	-96.0%	118975.15%
LONG-TERM LIABILITIES
Long-Term Debt	$5.821M	$2.331M	$12.83M
YoY Change	-54.63%
Other Long-Term Liabilities	$143.4K		$1.938M
YoY Change	-92.6%
Total Long-Term Liabilities	$5.964M	$2.331M	$28.35M
YoY Change	-78.96%	-92.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$8.638M	$5.782M	$143.6M
Total Long-Term Liabilities	$5.964M	$2.331M	$28.35M
Total Liabilities	$14.60M	$8.113M	$172.0M
YoY Change	-91.51%	-95.33%	142476.43%
SHAREHOLDERS EQUITY
Retained Earnings	-$16.30M	-$16.63M	-$7.455M
YoY Change	118.6%	76.22%	-41.25%
Common Stock	$133.0K	$127.1K	$114.6K
YoY Change	16.08%	23.57%	13.57%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.289M	$743.5K	$33.20M
YoY Change
Total Liabilities & Shareholders Equity	$16.47M	$8.857M	$205.2M
YoY Change	-91.97%	-95.59%	876348.88%

Cashflow Statement

Concept	2024 Q2	2023 Q4	2023 Q2
OPERATING ACTIVITIES
Net Income	$130.3K	-$4.162M	$2.853M
YoY Change	-95.43%	-262.21%	1062.24%
Depreciation, Depletion And Amortization	$37.56K	$0.00	$653.0K
YoY Change	-94.25%	-100.0%	15.58%
Cash From Operating Activities	-$1.356M	-$3.654M	$1.824M
YoY Change	-174.38%		-1399.94%
INVESTING ACTIVITIES
Capital Expenditures			-$625.3K
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$108.5K	-$5.500M
YoY Change
Cash From Investing Activities	$111.6K	-$4.622M	$625.3K
YoY Change	-82.15%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.373M	8.334M	-$1.971M
YoY Change	-169.66%		-1517.29%
NET CHANGE
Cash From Operating Activities	-1.356M	-3.654M	$1.824M
Cash From Investing Activities	111.6K	-4.622M	$625.3K
Cash From Financing Activities	1.373M	8.334M	-$1.971M
Net Change In Cash	128.2K	57.33K	$477.9K
YoY Change	-73.17%		-39498.85%
FREE CASH FLOW
Cash From Operating Activities	-$1.356M	-$3.654M	$1.824M
Capital Expenditures			-$625.3K
Free Cash Flow			$2.449M
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	000-56239
CY2023	dei	Entity Registrant Name EntityRegistrantName	QUALITY INDUSTRIAL CORP.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	35-2675388
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	315 Montgomery Street
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	San Francisco
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94104
CY2023	dei	City Area Code CityAreaCode	800
CY2023	dei	Local Phone Number LocalPhoneNumber	706-0806
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	4201441	usd
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	128026503	shares
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023	dei	Auditor Name AuditorName	Pipara & Co LLP
CY2023	dei	Auditor Firm AuditorFirmId	6841
CY2023	dei	Auditor Location AuditorLocation	Ahmedabad, India
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2492	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3136	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	2354083	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	10958	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	2356575	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	14094	usd
CY2023Q4	us-gaap	Long Term Investments LongTermInvestments	6500000	usd
CY2022Q4	us-gaap	Long Term Investments LongTermInvestments	1000000	usd
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	6500000	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	1000000	usd
CY2023Q4	us-gaap	Assets Assets	8856575	usd
CY2022Q4	us-gaap	Assets Assets	1014094	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	166577	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	27803	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	5615440	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	79230	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5782017	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	107033	usd
CY2023Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	2331059	usd
CY2022Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	1100000	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	2331059	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	1100000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	8113076	usd
CY2022Q4	us-gaap	Liabilities Liabilities	1207033	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	127129694	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	127129694	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	127132	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	102886	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	17248964	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	12174975	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-16632597	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-12470800	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	743499	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-192939	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	8856575	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1014094	usd
CY2023	us-gaap	Professional Fees ProfessionalFees	315011	usd
CY2022	us-gaap	Professional Fees ProfessionalFees	294700	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2389309	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	126846	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	2704320	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	421546	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-2704320	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-421546	usd
CY2023	us-gaap	Induced Conversion Of Convertible Debt Expense InducedConversionOfConvertibleDebtExpense	137448	usd
CY2022	us-gaap	Induced Conversion Of Convertible Debt Expense InducedConversionOfConvertibleDebtExpense	33838	usd
CY2023	qind	Shares Issued For Services SharesIssuedForServices	1320029	usd
CY2022	qind	Loss On License Agreement LossOnLicenseAgreement	104550	usd
CY2023	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	1457477	usd
CY2022	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	138388	usd
CY2022	qind	Gain On Settlement Forgiveness Of Debt GainOnSettlementForgivenessOfDebt	457071	usd
CY2023	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	0	usd
CY2022	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	457071	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-4161797	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-102863	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	114665519	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	100703471	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-192939	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2000000	usd
CY2023	qind	Stock Issued During Period Value Stock Issued To Management StockIssuedDuringPeriodValueStockIssuedToManagement	2233000	usd
CY2023	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	722735	usd
CY2023	qind	Stock Issued During Period Value Issued As Commitment Shares StockIssuedDuringPeriodValueIssuedAsCommitmentShares	126000	usd
CY2023	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	16500	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-4161797	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	743499	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-369007	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	57824	usd
CY2022	qind	Stock Issued During Period Value Issued For License Agreement StockIssuedDuringPeriodValueIssuedForLicenseAgreement	104550	usd
CY2022	qind	Adjustmentto Additional Paidin Capital Imputed Interest AdjustmenttoAdditionalPaidinCapitalImputedInterest	1498	usd
CY2022	qind	Adjustmentto Additional Paidin Capital Reclassification Of Imputed Interest AdjustmenttoAdditionalPaidinCapitalReclassificationOfImputedInterest	-6283	usd
CY2022	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	82600	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-102863	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-192939	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-4161797	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-102863	usd
CY2023	qind	Finance Cost FinanceCost	146447	usd
CY2022	qind	Finance Cost FinanceCost	33839	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	2233000	usd
CY2023	us-gaap	Other Noncash Income Tax Expense OtherNoncashIncomeTaxExpense	931476	usd
CY2022	qind	Gain Loss On License Agreement GainLossOnLicenseAgreement	104550	usd
CY2022	qind	Gain On Settlement And Forgiveness Of Debt GainOnSettlementAndForgivenessOfDebt	457071	usd
CY2023	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	2343125	usd
CY2022	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	10780	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	-210293	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	138774	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-179618	usd
CY2023	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	5536210	usd
CY2022	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-13486	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2480985	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-415136	usd
CY2023	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments	5500000	usd
CY2022	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments	1000000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5500000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1000000	usd
CY2023	us-gaap	Proceeds From Issuance Of Medium Term Notes ProceedsFromIssuanceOfMediumTermNotes	1245000	usd
CY2022	us-gaap	Proceeds From Issuance Of Medium Term Notes ProceedsFromIssuanceOfMediumTermNotes	1100000	usd
CY2022	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	295000	usd
CY2022	qind	Paymentto Loss On License Agreement PaymenttoLossOnLicenseAgreement	104550	usd
CY2022	qind	Proceed From Settlement And Forgiveness Of Debt ProceedFromSettlementAndForgivenessOfDebt	457071	usd
CY2023	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	161465	usd
CY2022	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	33839	usd
CY2023	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	65164	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	2000000	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	278931	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3018371	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1402613	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-644	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-12523	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3136	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15659	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2492	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3136	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3136	usd
CY2023Q2	us-gaap	Other Assets Current OtherAssetsCurrent	10958	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	14094	usd
CY2023Q2	us-gaap	Long Term Investments LongTermInvestments	1000000	usd
CY2023Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	1000000	usd
CY2023Q2	us-gaap	Assets Assets	1014094	usd
CY2023Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	27803	usd
CY2023Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	79230	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	107033	usd
CY2023Q2	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	1100000	usd
CY2023Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	1100000	usd
CY2023Q2	us-gaap	Liabilities Liabilities	1207033	usd
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	102883709	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	102883709	shares
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	102886	usd
CY2023Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	12174975	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-12470800	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-192939	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1014094	usd
CY2022	us-gaap	Professional Fees ProfessionalFees	294700	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	126846	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	421546	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-421546	usd
CY2022	qind	Interest On Convertible Notes InterestOnConvertibleNotes	33839	usd
CY2022	qind	Loss On License Agreement LossOnLicenseAgreement	104550	usd
CY2022	qind	Non Operating Expenses NonOperatingExpenses	138389	usd
CY2022	qind	Gain On Settlements Forgiveness Of Debt GainOnSettlementsForgivenessOfDebt	457071	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	457071	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-102863	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	100703471	shares
CY2022Q2	qind	Common Stock Transfer Shares CommonStockTransferShares	77669078	shares
CY2022Q2	qind	Common Stock Transfer Value CommonStockTransferValue	500000	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Use of estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">A critical accounting estimate is an estimate that: (i) is made in accordance with generally accepted accounting principles, (ii) involves a significant level of estimation uncertainty and (iii) has had or is reasonably likely to have a material impact on the Company’s financial condition or results of operations.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company’s Consolidated Financial Statements have been prepared in accordance with generally accepted accounting principles in the United States of America (U.S. GAAP). The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and judgments that affect reported amounts and related disclosures. On an ongoing basis, management evaluates and updates its estimates. Management employs judgment in making its estimates but they are based on historical experience and currently available information and various other assumptions that the Company believes to be reasonable under the circumstances. The results of these estimates form the basis for making judgments about the carrying values of assets and liabilities that are not readily available from other sources. Actual results could differ from those estimates. Management believes that its judgment is applied consistently and produces financial information that fairly depicts the results of operations for all periods presented.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Significant estimates include estimates used to review the Company’s, impairments and estimations of long-lived assets, revenue recognition of Contract based revenue, allowances for uncollectible accounts, and the valuations of non-cash capital stock issuances. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable in the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.</p>
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-4161797	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-102863	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4161797	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-102863	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	114665519	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	100703471	shares
CY2023	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	127129694	shares
CY2022	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	102883709	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	127379694	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	102883709	shares
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	10442	usd
CY2023Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	20950	usd
CY2023Q4	qind	Buy Back Commitments BuyBackCommitments	2000000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	333133	usd
CY2022Q4	us-gaap	Other Assets Miscellaneous Current OtherAssetsMiscellaneousCurrent	516	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	2354083	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	10958	usd
CY2023	us-gaap	Payments To Acquire Finance Receivables PaymentsToAcquireFinanceReceivables	333133	usd
CY2022	us-gaap	Payments To Acquire Finance Receivables PaymentsToAcquireFinanceReceivables	0	usd
CY2023Q4	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	1000000	usd
CY2023	qind	Working Capital WorkingCapital	100000	usd
CY2023	us-gaap	Debt Instrument Redemption Price Percentage Of Principal Amount Redeemed DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed	0.01	pure
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	5615440	usd
CY2023Q3	us-gaap	Securities Borrowed SecuritiesBorrowed	3000000	usd
CY2023Q3	us-gaap	Investment Company Committed Capital InvestmentCompanyCommittedCapital	3000000	usd
CY2023Q3	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	6410971	shares
CY2023Q3	us-gaap	Dividends Common Stock DividendsCommonStock	2000000	usd
CY2023Q3	us-gaap	Investment Company Committed Capital InvestmentCompanyCommittedCapital	2000000	usd
CY2023Q4	us-gaap	Debt Instrument Periodic Payment Interest DebtInstrumentPeriodicPaymentInterest	20	usd
CY2023Q4	qind	Interest Percentage InterestPercentage	0.15	pure
CY2023Q4	us-gaap	Debt Instrument Convertible Remaining Discount Amortization Period1 DebtInstrumentConvertibleRemainingDiscountAmortizationPeriod1	P1Y
CY2023Q4	us-gaap	Debt Conversion Converted Instrument Rate DebtConversionConvertedInstrumentRate	0.25	pure
CY2023Q4	us-gaap	Investment Company Total Return Market Value InvestmentCompanyTotalReturnMarketValue	0.50	pure
CY2020Q2	us-gaap	Loans Payable LoansPayable	30215	usd
CY2020Q3	us-gaap	Loans Payable LoansPayable	15000	usd
CY2020Q4	us-gaap	Loans Payable LoansPayable	7875	usd
CY2022Q2	us-gaap	Debt Instrument Increase Accrued Interest DebtInstrumentIncreaseAccruedInterest	506	usd
CY2020Q4	us-gaap	Loans Payable LoansPayable	10000	usd
CY2022Q1	us-gaap	Debt Instrument Increase Accrued Interest DebtInstrumentIncreaseAccruedInterest	477	usd
CY2022Q2	us-gaap	Loans Payable LoansPayable	37000	usd
CY2022Q2	us-gaap	Debt Instrument Increase Accrued Interest DebtInstrumentIncreaseAccruedInterest	30	usd
CY2022Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	37030	usd
CY2022Q2	us-gaap	Investment Interest Rate InvestmentInterestRate	0.51	pure
CY2022Q2	us-gaap	Interest And Fee Income Other Loans InterestAndFeeIncomeOtherLoans	300041	usd
CY2023Q2	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	200000	shares
CY2023Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.58
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	127129694	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	102883709	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q1	qind	Percentage Of Agreement To Acquire PercentageOfAgreementToAcquire	0.51	pure
CY2023	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	2363000	usd
CY2023	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	1655	usd
CY2023	us-gaap	Other General Expense OtherGeneralExpense	14356	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1331	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2389309	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2233000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	0	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	0	usd
CY2022Q2	us-gaap	Loans Receivable With Variable Rates Of Interest1 LoansReceivableWithVariableRatesOfInterest1	37000	usd
CY2022Q2	us-gaap	Deposit Liabilities Accrued Interest DepositLiabilitiesAccruedInterest	30	usd
CY2022Q2	us-gaap	Debt Instrument Decrease Forgiveness DebtInstrumentDecreaseForgiveness	37030	usd
CY2022Q2	us-gaap	Asset Acquisition Consideration Transferred AssetAcquisitionConsiderationTransferred	51	usd
CY2022Q2	us-gaap	Interest Income Other InterestIncomeOther	300041	usd
CY2021Q4	us-gaap	Principal Amount Outstanding On Loans Securitized PrincipalAmountOutstandingOnLoansSecuritized	120000	usd
CY2022Q1	us-gaap	Noncash Or Part Noncash Acquisition Interest Acquired1 NoncashOrPartNoncashAcquisitionInterestAcquired1	0.51	pure
CY2022Q1	us-gaap	Common Stock Shares Held In Employee Trust Shares CommonStockSharesHeldInEmployeeTrustShares	2550000	shares
CY2022Q1	us-gaap	Common Stock Held In Trust CommonStockHeldInTrust	104550	usd
CY2022Q2	us-gaap	Line Of Credit Assumed1 LineOfCreditAssumed1	300000	usd
CY2022Q2	us-gaap	Interest Receivable InterestReceivable	41	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet		usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess		usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess		usd
CY2023Q4	us-gaap	Fixtures And Equipment Gross FixturesAndEquipmentGross		usd
CY2022Q4	us-gaap	Fixtures And Equipment Gross FixturesAndEquipmentGross		usd
CY2023Q4	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements		usd
CY2022Q4	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements		usd
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset		usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset		usd
CY2023Q4	us-gaap	Goodwill Goodwill		usd
CY2022Q4	us-gaap	Goodwill Goodwill		usd
CY2023Q4	us-gaap	Liabilities Other Than Longterm Debt Noncurrent LiabilitiesOtherThanLongtermDebtNoncurrent		usd
CY2022Q4	us-gaap	Liabilities Other Than Longterm Debt Noncurrent LiabilitiesOtherThanLongtermDebtNoncurrent		usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q4	us-gaap	Restructuring Reserve RestructuringReserve		usd
CY2022Q4	us-gaap	Restructuring Reserve RestructuringReserve		usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest		usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest		usd
CY2023	us-gaap	Revenues Revenues		usd
CY2022	us-gaap	Revenues Revenues		usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue		usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue		usd
CY2023	us-gaap	Gross Profit GrossProfit		usd
CY2022	us-gaap	Gross Profit GrossProfit		usd
CY2023	us-gaap	Interest Expense InterestExpense		usd
CY2022	us-gaap	Interest Expense InterestExpense		usd
CY2022	qind	Shares Issued For Services SharesIssuedForServices		usd
CY2023	qind	Loss On License Agreement LossOnLicenseAgreement		usd
CY2023	us-gaap	Gain Loss On Investments GainLossOnInvestments		usd
CY2023	qind	Depreciation Non Operating DepreciationNonOperating		usd
CY2022	qind	Depreciation Non Operating DepreciationNonOperating		usd
CY2023	us-gaap	Other Nonoperating Income OtherNonoperatingIncome		usd
CY2022	us-gaap	Other Nonoperating Income OtherNonoperatingIncome		usd
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2022	qind	Adjustmentto Reversal Stock Payable AdjustmenttoReversalStockPayable		usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation		usd
CY2022	us-gaap	Other Noncash Income Tax Expense OtherNoncashIncomeTaxExpense		usd
CY2023	qind	Gain Loss On License Agreement GainLossOnLicenseAgreement		usd
CY2023	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther		usd
CY2023	qind	Paymentto Long Term Borrowings PaymenttoLongTermBorrowings		usd
CY2022	qind	Paymentto Long Term Borrowings PaymenttoLongTermBorrowings		usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations		usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations		usd
CY2023	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit		usd
CY2023	qind	Paymentto Loss On License Agreement PaymenttoLossOnLicenseAgreement		usd
CY2023	us-gaap	Proceeds From Repayments Of Other Debt ProceedsFromRepaymentsOfOtherDebt		usd
CY2022	us-gaap	Proceeds From Repayments Of Other Debt ProceedsFromRepaymentsOfOtherDebt		usd
CY2023	qind	Proceed From Paymentto Subsidiary ProceedFromPaymenttoSubsidiary		usd
CY2022	qind	Proceed From Paymentto Subsidiary ProceedFromPaymenttoSubsidiary		usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet		usd
CY2023Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess		usd
CY2023Q2	us-gaap	Fixtures And Equipment Gross FixturesAndEquipmentGross		usd
CY2023Q2	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements		usd
CY2023Q2	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset		usd
CY2023Q2	us-gaap	Goodwill Goodwill		usd
CY2023Q2	us-gaap	Liabilities Other Than Longterm Debt Noncurrent LiabilitiesOtherThanLongtermDebtNoncurrent		usd
CY2023Q2	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2023Q2	us-gaap	Restructuring Reserve RestructuringReserve		usd
CY2023Q2	us-gaap	Minority Interest MinorityInterest		usd
CY2022	us-gaap	Revenues Revenues		usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue		usd
CY2022	us-gaap	Gross Profit GrossProfit		usd
CY2022	us-gaap	Interest Expense InterestExpense		usd
CY2022	qind	Shares Issued For Services SharesIssuedForServices		usd
CY2022	us-gaap	Gain Loss On Investments GainLossOnInvestments		usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization		usd
CY2022	us-gaap	Other Nonoperating Income OtherNonoperatingIncome		usd
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2022Q1	us-gaap	Investment Company Equity Security Fv Ni Contractual Sale Restriction Remaining Period InvestmentCompanyEquitySecurityFvNiContractualSaleRestrictionRemainingPeriod	P2Y
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001393781

Files In Submission

Name	View Source	Status
0001213900-24-030968-index-headers.html	Edgar Link	pending
0001213900-24-030968-index.html	Edgar Link	pending
0001213900-24-030968.txt	Edgar Link	pending
0001213900-24-030968-xbrl.zip	Edgar Link	pending
ea0202774-10k_quality.htm	Edgar Link	pending
ea020277401ex10-10_quality.htm	Edgar Link	pending
ea020277401ex10-11_quality.htm	Edgar Link	pending
ea020277401ex10-12_quality.htm	Edgar Link	pending
ea020277401ex10-13_quality.htm	Edgar Link	pending
ea020277401ex10-14_quality.htm	Edgar Link	pending
ea020277401ex31-1_quality.htm	Edgar Link	pending
ea020277401ex31-2_quality.htm	Edgar Link	pending
ea020277401ex32-1_quality.htm	Edgar Link	pending
ea020277401ex4-16_quality.htm	Edgar Link	pending
ea020277401ex4-17_quality.htm	Edgar Link	pending
ea020277401ex4-18_quality.htm	Edgar Link	pending
ea020277401ex4-19_quality.htm	Edgar Link	pending
ex10-10_001.jpg	Edgar Link	pending
ex10-10_002.jpg	Edgar Link	pending
ex10-10_003.jpg	Edgar Link	pending
ex10-10_004.jpg	Edgar Link	pending
ex10-10_005.jpg	Edgar Link	pending
ex10-10_006.jpg	Edgar Link	pending
ex10-10_007.jpg	Edgar Link	pending
ex10-10_008.jpg	Edgar Link	pending
ex10-10_009.jpg	Edgar Link	pending
ex10-10_010.jpg	Edgar Link	pending
ex10-10_011.jpg	Edgar Link	pending
ex10-10_012.jpg	Edgar Link	pending
ex10-10_013.jpg	Edgar Link	pending
ex10-10_014.jpg	Edgar Link	pending
ex10-10_015.jpg	Edgar Link	pending
ex10-11_001.jpg	Edgar Link	pending
ex10-11_002.jpg	Edgar Link	pending
ex10-12_001.jpg	Edgar Link	pending
ex10-12_002.jpg	Edgar Link	pending
ex10-13_001.jpg	Edgar Link	pending
ex10-14_001.jpg	Edgar Link	pending
ex10-14_002.jpg	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
image_002.jpg	Edgar Link	pending
image_003.jpg	Edgar Link	pending
image_004.jpg	Edgar Link	pending
image_005.jpg	Edgar Link	pending
image_006.jpg	Edgar Link	pending
image_007.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
qind-20231231.xsd	Edgar Link	pending
ea0202774-10k_quality_htm.xml	Edgar Link	completed
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
qind-20231231_def.xml	Edgar Link	unprocessable
qind-20231231_lab.xml	Edgar Link	unprocessable
qind-20231231_pre.xml	Edgar Link	unprocessable
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
qind-20231231_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$QIND
Quality Industrial Corp. Stock $qind

2024 Q2 Form 10-K Financial Statement

#000121390024030968 Filed on April 08, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$QIND Quality Industrial Corp. Stock $qind

2024 Q2 Form 10-K Financial Statement

#000121390024030968 Filed on April 08, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$QIND
Quality Industrial Corp. Stock $qind